Dr. Robert A. Nagourney, MD
New Cancer Drug: Breakthrough or Just Hype?
Having just passed through Ontario’s Pearson International airport on route from eastern Canada, I was struck by an email from one of my...
top of page
Cancer Blog
- Dr. Robert Nagourney -
Search
Dr. Robert A. Nagourney, MD
Jul 8, 20133 min read
Functional Profiling Identifies Accurate Genomic Findings
The 2013 American Society of Clinical Oncology annual meeting, held May 31 – June 1, in Chicago, afforded the opportunity to report three...
Dr. Robert A. Nagourney, MD
Jun 10, 20132 min read
Evidence Based Medicine and the Cost of Cancer Care
Before I attended the ASCO meeting in Chicago, I penned a blog about a Forbes magazine article that described increasing restrictions...
Dr. Robert A. Nagourney, MD
Jun 5, 20133 min read
The High Cost of Cancer Care
An article by Scott Gottlieb, MD, in Forbes (Medicare Nixes Coverage for New Cancer Tests), described Medicare reimbursement for new...
Dr. Robert A. Nagourney, MD
May 23, 20132 min read
The Angelina Jolie Effect
Angelina Jolie’s willingness to bravely publish her saga, as she confronts the risk of a nefarious form of cancer, has focused...
Dr. Robert A. Nagourney, MD
May 19, 20132 min read
Personalized Cancer Care: N-of-1
The New York Yankees catcher Yogi Berra famous quote, “Déjà vu all over again,” reminds me of the growing focus on the concept of “N-...
Dr. Robert A. Nagourney, MD
Apr 24, 20133 min read
The Future of Cancer Research
The American Association for Cancer Research meeting held April 6 - 10 in Washington DC, provided a scientific perspective on oncologic...
Dr. Robert A. Nagourney, MD
Apr 18, 20131 min read
Cancer as a Metabolic Disorder
I received an inquiry via Twitter “Has anyone thought about using a sugar medium (similar to PET scans) to deliver chemo drugs?” Although...
Dr. Robert A. Nagourney, MD
Apr 4, 20132 min read
Is There a Role for Maintenance Therapy in Cancer Treatment?
There is a long tradition of maintenance therapy in pediatric oncology. Children with acute lymphoblastic leukemia or ALL uniformly...
Dr. Robert A. Nagourney, MD
Mar 31, 20132 min read
Cure the Curable, Treat the Treatable and Avoid Futile Care
During my interview with Jeff Michaels on the March 28, 5:00 P.M. Fox News, we explored the themes of my current book, Outliving Cancer....
Dr. Robert A. Nagourney, MD
Mar 26, 20132 min read
Cancer Medicine – A Humbling Experience
In his brilliant 1998 book, Consilience, Edward O. Wilson, notes: “The cost of scientific advance is the humbling recognition that...
Dr. Robert A. Nagourney, MD
Mar 7, 20132 min read
HER2 in Stomach Cancer and Breast Cancer
I met a charming patient in my office this week. A gentleman with advanced gastric (stomach) cancer. Upon further examination of his...
Dr. Robert A. Nagourney, MD
Feb 9, 20132 min read
Chemosensitivity Testing Captures Attention of "Nature Biotechnology"
An interesting editorial appeared in the February 2013 issue of Nature Biotechnology titled “Dishing out cancer treatment.” The lead line...
Dr. Robert A. Nagourney, MD
Feb 6, 20132 min read
What is Cancer?
This is a question that has vexed scientific investigators for centuries, and for the last century, our belief was predicated upon...
Dr. Robert A. Nagourney, MD
Jan 29, 20133 min read
A “Clinical Trial” Gone Too Far - Hormone Refractory Prostate Cancer
An interesting paper was published in the January 10 NEJM (Abiraterone in Metastatic Prostate Cancer with Previous Chemotherapy, Ryan et...
Dr. Robert A. Nagourney, MD
Jan 18, 20132 min read
Yet Another Study Agrees: Functional Profiling Provides Insight
It was during the last weeks of December that a particularly interesting article crossed my desk. The study done by a group from Toronto,...
Dr. Robert A. Nagourney, MD
Dec 22, 20122 min read
Cancer and the Great Divide - A Look at a Childhood ALL study
There are two types of cancer patients: those we can treat and those we can’t. As I reflect on this year and the years past during which...
Dr. Robert A. Nagourney, MD
Dec 18, 20124 min read
Phar Lap and the Treatment of Leukemia
Phar Lap (1926-1932) was a thoroughbred horse bred in New Zealand. After winning the Melbourne Cup and 37 other races, his victory at the...
bottom of page